Sanofi(DE:SNW)
€86.41+0.43 (+0.50%)
DE:SNW
Sanofi stock forecast
€86.41
At close:+0.43 (+0.50%)
Sanofi (SNW) Stock Forecast & Price Target
35 Followers
SNW Analyst Ratings
Moderate Buy
8Buy6Hold0Sell
Based on 14 analysts giving stock ratings to Sanofi in the past 3 months
SNW Stock 12 Month Forecast
Average Price Target
€95.15▲(10.12% Upside)Based on 14 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is EUR 95.15 with a high forecast of EUR 110.00 and a low forecast of EUR 80.00. The average price target represents a 10.12% change from the last price of EUR 86.41.
Past 12 Months12 Month ForecastJan2026Oct2026
High€110.00
Average€95.15
Low€80.00
Highest Price TargetHighest€110.00Average Price Target€95.15Lowest Price TargetLowest€80.00
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Matthew Weston | UBS | €78→€88 | hold | 1.84%Upside | Reiterated | 11/09/26 | ||
| Peter Verdult | Exane BNP Paribas | €102 | buy | 18.04%Upside | Upgraded | 11/09/26 | ||
| Emmanuel Papadakis | Deutsche Bank | €95 | buy | 9.94%Upside | Reiterated | 11/06/26 | ||
| Richard Vosser | J.P. Morgan | €95 | hold | 9.94%Upside | Reiterated | 11/04/26 | ||
| Luisa Hector | Berenberg Bank | €105 | buy | 21.51%Upside | Reiterated | 11/04/26 | ||
| Justin Smith | Bernstein | €106.21→€110 | buy | 27.30%Upside | Reiterated | 11/04/26 | ||
| Elmar Kraus | DZ BANK AG | ― | buy | ― | Reiterated | 11/04/26 | ||
| Thibault Boutherin | Morgan Stanley | €82→€86 | hold | -0.47%Downside | Reiterated | 11/03/26 | ||
| Trung Huynh | RBC Capital | €75→€80 | hold | -7.42%Downside | Reiterated | 11/02/26 | ||
| James Gordon CFA | Barclays | €83→€90 | hold | 4.15%Upside | Reiterated | 11/02/26 | ||
| Michael Leuchten | Jefferies | €100 | buy | 15.73%Upside | Reiterated | 10/30/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | €94 | buy | 8.78%Upside | Reiterated | 10/19/26 | ||
| Sachin Jain | Bank of America Securities | €92 | hold | 6.47%Upside | Reiterated | 10/08/26 | ||
| Rajesh Kumar | HSBC | €95→€100 | buy | 15.73%Upside | Reiterated | 09/10/26 | ||
| James Quigley | Goldman Sachs | €89→€84 | hold | -2.79%Downside | Reiterated | 07/06/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Matthew WestonUBS | HoldReiterated€78→€88 | 11/09/26 | 1.84%Upside | ||
| Peter VerdultExane BNP Paribas | BuyUpgraded€102 | 11/09/26 | 18.04%Upside | ||
| Emmanuel PapadakisDeutsche Bank | BuyReiterated€95 | 11/06/26 | 9.94%Upside | ||
| Richard VosserJ.P. Morgan | HoldReiterated€95 | 11/04/26 | 9.94%Upside | ||
| Luisa HectorBerenberg Bank | BuyReiterated€105 | 11/04/26 | 21.51%Upside | ||
| Justin SmithBernstein | BuyReiterated€106.21→€110 | 11/04/26 | 27.30%Upside | ||
| Elmar KrausDZ BANK AG | BuyReiterated | 11/04/26 | ― | ||
| Thibault BoutherinMorgan Stanley | HoldReiterated€82→€86 | 11/03/26 | -0.47%Downside | ||
| Trung HuynhRBC Capital | HoldReiterated€75→€80 | 11/02/26 | -7.42%Downside | ||
| James Gordon CFABarclays | HoldReiterated€83→€90 | 11/02/26 | 4.15%Upside | ||
| Michael LeuchtenJefferies | BuyReiterated€100 | 10/30/26 | 15.73%Upside | ||
| Unknown AnalystLeerink PartnersNot Ranked | BuyReiterated€94 | 10/19/26 | 8.78%Upside | ||
| Sachin JainBank of America Securities | HoldReiterated€92 | 10/08/26 | 6.47%Upside | ||
| Rajesh KumarHSBC | BuyReiterated€95→€100 | 09/10/26 | 15.73%Upside | ||
| James QuigleyGoldman Sachs | HoldReiterated€89→€84 | 07/06/26 | -2.79%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Sanofi
3 Months
Success Rate16/27 ratings generated profit
59%
Average Return
+1.79%
Copying Luisa Hector's trades and holding each position for 3 Months would result in 59.26% of your transactions generating a profit, with an average return of +1.79% per trade.
1 Year
Success Rate17/27 ratings generated profit
63%
Average Return
+2.56%
Copying Luisa Hector's trades and holding each position for 1 Year would result in 62.96% of your transactions generating a profit, with an average return of +2.56% per trade.
2 Years
Success Rate20/26 ratings generated profit
77%
Average Return
+8.15%
Copying Florent Cespedes's trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +8.15% per trade.
SNW Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 |
| Buy | 10 | 14 | 15 | 15 | 15 |
| Hold | 12 | 13 | 17 | 16 | 19 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 27 | 32 | 32 | 35 |
In the current month, SNW has received 16 Buy Ratings, 19 Hold Ratings, and 0 Sell Ratings. SNW average Analyst price target in the past 3 months is 95.15.
SNW Financial Forecast
High€2.11
Consensus€1.73
Low€1.37
SNW Earnings Forecast
Next quarter’s earnings estimate for SNW is EUR 1.73 with a range of EUR 1.37 to EUR 2.11. The previous quarter’s EPS was EUR 3.55. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€14B
Consensus€13.4B
Low€12.8B
SNW Sales Forecast
Next quarter’s sales forecast for SNW is EUR 13.40B with a range of EUR 12.77B to EUR 14.01B. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
SNW Stock Forecast FAQ
What is DE:SNW’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is €95.15.
What is DE:SNW’s upside potential, based on the analysts’ average price target?
Sanofi has 10.12% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sanofi a Buy, Sell or Hold?
Sanofi has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 6 hold ratings and 0 sell ratings.
What is Sanofi’s share price target?
The average share price target for Sanofi is €95.15. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €110.00, and the lowest forecast is €80.00. The average share price target represents a 10.12% increase from the current price of €86.41.
What do analysts say about Sanofi?
Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of Sanofi?
To buy shares of DE:SNW, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
